First generation mTOR inhibitors rapamycin and its ester analogue CCI-779 (Temsirolimus) not only inhibited growth and induced cell death in several MYCN-amplified NB cells, but also significantly reduced MYCN protein levels (148). This evidence concerns the gene MYCN and neuroblastoma.